These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25529455)

  • 81. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Biologic effects of parathyroid hormone metabolites: implications for renal bone disease.
    Akhtar I; González EA
    J Investig Med; 2004 Jan; 52(1):51-7. PubMed ID: 14989370
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Relationship between endogenous parathyroid hormone and bone metabolism/geometry in female patients treated with glucocorticoid.
    Kaji H; Yamauchi M; Chihara K; Sugimoto T
    Horm Metab Res; 2008 Jan; 40(1):60-5. PubMed ID: 18072075
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Pregnancy-associated plasma protein-A modulates the anabolic effects of parathyroid hormone in mouse bone.
    Clifton KB; Conover CA
    Bone; 2015 Dec; 81():413-416. PubMed ID: 26297833
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effect of impact exercise on bone metabolism.
    Vainionpää A; Korpelainen R; Väänänen HK; Haapalahti J; Jämsä T; Leppäluoto J
    Osteoporos Int; 2009 Oct; 20(10):1725-33. PubMed ID: 19262975
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Bisphosphonate maintains parathyroid hormone (1-34)-induced cortical bone mass and mechanical strength in old rats.
    Ejersted C; Oxlund H; Andreassen TT
    Calcif Tissue Int; 1998 Apr; 62(4):316-22. PubMed ID: 9504956
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The anabolic response to parathyroid hormone is augmented in Rac2 knockout mice.
    Kawano T; Troiano N; Adams DJ; Wu JJ; Sun BH; Insogna K
    Endocrinology; 2008 Aug; 149(8):4009-15. PubMed ID: 18467443
    [TBL] [Abstract][Full Text] [Related]  

  • 88. In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment.
    Stanislaus D; Yang X; Liang JD; Wolfe J; Cain RL; Onyia JE; Falla N; Marder P; Bidwell JP; Queener SW; Hock JM
    Bone; 2000 Aug; 27(2):209-18. PubMed ID: 10913913
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis.
    Hodsman AB; Kisiel M; Adachi JD; Fraher LJ; Watson PH
    Bone; 2000 Aug; 27(2):311-8. PubMed ID: 10913928
    [TBL] [Abstract][Full Text] [Related]  

  • 90. RANKL/OPG system regulation by endogenous PTH and PTH1R/ATF4 axis in bone: Implications for bone accrual and strength in growing rats with mild uremia.
    Znorko B; Pawlak D; Oksztulska-Kolanek E; Domaniewski T; Pryczynicz A; Roszczenko A; Rogalska J; Lipowicz P; Doroszko M; Brzoska MM; Pawlak K
    Cytokine; 2018 Jun; 106():19-28. PubMed ID: 29529595
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Infrequent delivery of a long-acting PTH-Fc fusion protein has potent anabolic effects on cortical and cancellous bone.
    Kostenuik PJ; Ferrari S; Pierroz D; Bouxsein M; Morony S; Warmington KS; Adamu S; Geng Z; Grisanti M; Shalhoub V; Martin S; Biddlecome G; Shimamoto G; Boone T; Shen V; Lacey D
    J Bone Miner Res; 2007 Oct; 22(10):1534-47. PubMed ID: 17576164
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The influence of combined parathyroid hormone and growth hormone treatment on cortical bone in aged ovariectomized rats.
    Andreassen TT; Oxlund H
    J Bone Miner Res; 2000 Nov; 15(11):2266-75. PubMed ID: 11092409
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
    Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
    Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
    [TBL] [Abstract][Full Text] [Related]  

  • 94. ATF936, a novel oral calcilytic, increases bone mineral density in rats and transiently releases parathyroid hormone in humans.
    John MR; Widler L; Gamse R; Buhl T; Seuwen K; Breitenstein W; Bruin GJ; Belleli R; Klickstein LB; Kneissel M
    Bone; 2011 Aug; 49(2):233-41. PubMed ID: 21514409
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Parathyroid hormone stimulation of noncanonical Wnt signaling in bone.
    Bergenstock MK; Partridge NC
    Ann N Y Acad Sci; 2007 Nov; 1116():354-9. PubMed ID: 18083937
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Parathyroid hormone attenuates osteoarthritis pain by remodeling subchondral bone in mice.
    Sun Q; Zhen G; Li TP; Guo Q; Li Y; Su W; Xue P; Wang X; Wan M; Guan Y; Dong X; Li S; Cai M; Cao X
    Elife; 2021 Mar; 10():. PubMed ID: 33646122
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Beta-arrestin-biased parathyroid hormone ligands: a new approach to the development of agents that stimulate bone formation.
    Ferrari SL; Bouxsein ML
    Sci Transl Med; 2009 Oct; 1(1):1ps1. PubMed ID: 20368152
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Improving Combination Osteoporosis Therapy in a Preclinical Model of Heightened Osteoanabolism.
    Shao Y; Hernandez-Buquer S; Childress P; Stayrook KR; Alvarez MB; Davis H; Plotkin LI; He Y; Condon KW; Burr DB; Warden SJ; Robling AG; Yang FC; Wek RC; Allen MR; Bidwell JP
    Endocrinology; 2017 Sep; 158(9):2722-2740. PubMed ID: 28637206
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Effects of load-bearing exercise on skeletal structure and mechanics differ between outbred populations of mice.
    Wallace IJ; Judex S; Demes B
    Bone; 2015 Mar; 72():1-8. PubMed ID: 25460574
    [TBL] [Abstract][Full Text] [Related]  

  • 100. TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling.
    Qiu T; Wu X; Zhang F; Clemens TL; Wan M; Cao X
    Nat Cell Biol; 2010 Mar; 12(3):224-34. PubMed ID: 20139972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.